Production value of antineoplastics Japan 2015, by category
The statistic shows the drug production value of antineoplastics in Japan in 2015, broken down by sub therapeutic category. In 2015, the production value of antimetabolites made up the largest share with approximately 35 billion Japanese yen, followed by antitumor plant extract preparations with a production value of around 18 billion yen.